Patient-centricity in digital measure development: co-evolution of best practice and regulatory guidance
Digital health technologies (DHTs) have the potential to modernize drug development and clinical trial operations by remotely, passively, and continuously collecting ecologically valid evidence that is meaningful to patients’ lived experiences. Such evidence holds…
Continue Reading